Pregled bibliografske jedinice broj: 1165482
Potential radioprotective properties of arbutin against ionising radiation on human leukocytes in vitro
Potential radioprotective properties of arbutin against ionising radiation on human leukocytes in vitro // Mutation research. Genetic toxicology and environmental mutagenesis, 872 (2021), 12; 503413, 30 doi:10.1016/j.mrgentox.2021.503413 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1165482 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Potential radioprotective properties of arbutin
against ionising radiation on human leukocytes in
vitro
Autori
Benković, Vesna ; Marčina, Nives ; Horvat Knežević, Anica ; Šikić, Dunja ; Rajevac, Vedran ; Milić, Mirta ; Kopjar, Nevenka
Izvornik
Mutation research. Genetic toxicology and environmental mutagenesis (1383-5718) 872
(2021), 12;
503413, 30
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Arbutin ; CBMN assay ; Comet assay ; Human leukocytes ; Ionising radiation
Sažetak
Arbutin is a simple phenolic glucoside biosynthesised in many plant families. Some of the everyday foods that contain arbutin are species of the genus Origanum, peaches, cereal products, coffee and tea and Arctostaphyllos uva ursi L. leaves. Arbutin possesses various beneficial effects in the organism, and was confirmed effective in the treatment of urinary tract infections as well as in preventing skin hyperpigmentation. It shows antioxidant and anti- inflammatory properties, and antitumor activity. The aim of this study was to explore potential radioprotective properties of arbutin in concentrations of 11.4 μg/mL, 57 μg/mL, 200 μg/mL and 400 μg/mL administered as a pre-treatment for one hour before exposing human leukocytes to ionising radiation at a therapeutic dose of 2 Gy. The alkaline comet assay was used to establish the levels of primary DNA damage, and cytokinesis- block micronucleus (CBMN) cytome assay to determine the level of cytogenetic damage. None of the tested concentrations of single arbutin showed genotoxic and cytotoxic effects. Even at the lowest tested concentration, 11.4 μg/mL, arbutin demonstrated remarkable potential for radioprotection in vitro, observed both at the level of primary DNA damage, and using CBMN cytome assay. The best dose reduction compared with amifostine was observed after pre-treatment with the highest concentration of arbutin, corresponding to 400 μg/mL. Promising results obtained on the leukocyte model speak in favour of extending similar experiments on other cell and animal models.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Javno zdravstvo i zdravstvena zaštita, Farmacija, Biotehnologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Prirodoslovno-matematički fakultet, Zagreb
Profili:
Dunja Šikić
(autor)
Mirta Milić
(autor)
Vesna Benković
(autor)
Anica Horvat Knežević
(autor)
Nevenka Kopjar
(autor)
Vedran Rajevac
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE